Nature出版增刊关注传统中医药

2011-12-24 MedSci MedSci原创

12月22日的《自然》杂志出版增刊——《亚洲传统医学》(Traditional Asian Medicine),介绍了中国和日本的传统医学的发展情况。增刊导言说,利用科学技术探究在中国和日本实践的传统医学,有助从迷信中甄选出有效的疗法。而且,草药疗法几千年的整体分析方法或许还能对现代医学有些启迪。 增刊包含多篇文章,对中国传统医学的历史、现代化、专利等问题进行了阐述。其中由记者徐治国撰写的文

12月22日的《自然》杂志出版增刊——《亚洲传统医学》(Traditional Asian Medicine),介绍了中国和日本的传统医学的发展情况。增刊导言说,利用科学技术探究在中国和日本实践的传统医学,有助从迷信中甄选出有效的疗法。而且,草药疗法几千年的整体分析方法或许还能对现代医学有些启迪。

增刊包含多篇文章,对中国传统医学的历史、现代化、专利等问题进行了阐述。其中由记者徐治国撰写的文章——《现代化:一步一个脚印》(Modernization: One step at a time),回顾了屠呦呦和张亭栋在中医药领域取得的成果,并称现代药物开发者可从传统中医药中借鉴许多有用的东西,但是研究人员首先必须明确和测试草药混合物。(生物谷 Bioon.com)

《自然》增刊(英文):http://www.nature.com/nature/outlook/asian_medicine/index.html

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=7054, encodeId=0cebe0542e, content=有利于中医药的发展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=873494523, createdName=liyuxia, createdTime=Thu Jan 23 22:41:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879107, encodeId=4a8918e91077d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Mar 04 14:18:00 CST 2012, time=2012-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408584, encodeId=e0e9140858430, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 26 09:18:00 CST 2011, time=2011-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3846, encodeId=e915384645, content=对我祖国医学有一定促进意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=090d49833, createdName=LaserDermatol, createdTime=Sun Dec 25 23:00:00 CST 2011, time=2011-12-25, status=1, ipAttribution=)]
    2014-01-23 liyuxia

    有利于中医药的发展!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=7054, encodeId=0cebe0542e, content=有利于中医药的发展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=873494523, createdName=liyuxia, createdTime=Thu Jan 23 22:41:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879107, encodeId=4a8918e91077d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Mar 04 14:18:00 CST 2012, time=2012-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408584, encodeId=e0e9140858430, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 26 09:18:00 CST 2011, time=2011-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3846, encodeId=e915384645, content=对我祖国医学有一定促进意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=090d49833, createdName=LaserDermatol, createdTime=Sun Dec 25 23:00:00 CST 2011, time=2011-12-25, status=1, ipAttribution=)]
    2012-03-04 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=7054, encodeId=0cebe0542e, content=有利于中医药的发展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=873494523, createdName=liyuxia, createdTime=Thu Jan 23 22:41:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879107, encodeId=4a8918e91077d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Mar 04 14:18:00 CST 2012, time=2012-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408584, encodeId=e0e9140858430, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 26 09:18:00 CST 2011, time=2011-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3846, encodeId=e915384645, content=对我祖国医学有一定促进意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=090d49833, createdName=LaserDermatol, createdTime=Sun Dec 25 23:00:00 CST 2011, time=2011-12-25, status=1, ipAttribution=)]
    2011-12-26 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=7054, encodeId=0cebe0542e, content=有利于中医药的发展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=873494523, createdName=liyuxia, createdTime=Thu Jan 23 22:41:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879107, encodeId=4a8918e91077d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Mar 04 14:18:00 CST 2012, time=2012-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408584, encodeId=e0e9140858430, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 26 09:18:00 CST 2011, time=2011-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3846, encodeId=e915384645, content=对我祖国医学有一定促进意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=090d49833, createdName=LaserDermatol, createdTime=Sun Dec 25 23:00:00 CST 2011, time=2011-12-25, status=1, ipAttribution=)]
    2011-12-25 LaserDermatol

    对我祖国医学有一定促进意义

    0

相关资讯

2010年中国科技论文统计出炉,生物医药领域表现不俗

中国科技信息研究所(下称中信所)12月2日对外发布了2010年中国科技论文(下称国际论文)统计结果。 2010年,我国机构作者为第一作者发表的国际论文共12.15万篇,其中23968篇论文的被引用次数高于学科均线,即其论文发表后的影响超过其所在学科的一般水平,也就是说占我国论文总数的19.7%的论文表现不俗,该比例较2009年的15.5%上升了4.2个百分点。我国表现不俗的论文 81.6%由

在Nature上如何发表Correspondence类文章?

对于Nature 上发表关于某中国期刊投稿中31%的剽窃(抄袭)率和国人的这种剽窃(抄袭)行为与中国古代文化相关的观点,我曾经进行过评论。主要观点是:1)一个中国期刊不能代表所有的中国期刊(好像现在改为International了);2)抄袭和剽窃行为,是个人学术修养问题,不能怪罪中国古代文化。   为此,我们一起讨论了一篇Correspondence 投往Nature, 表达了这种

Nature刊文讨论论文编辑服务

MedSci评论:确实随着全球对SCI论文的追逐,以及时间的紧迫。中国作者处理一篇中文文章,从翻译到仔细修改,往往需要三个月,甚至半年时间,而且最终质量仍然难以保证。而MedSci等论文编辑公司,往往在半个月左右或略长时间便能非常完美地将您的论文呈现出来,节约了科研临床人员宝贵的时间,而且质量更高。     但是,随着市场的发展,鱼目混珠的现象越来越多。一方面许多公